EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSFCAG00000004071
Gene Symbol: MIF
5 Cross references
219 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSFCAG00000024379
Gene Symbol: MGAM
5 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSFCAG00000015791
Gene Symbol: MMP1
5 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSFCAG00000010982
Gene Symbol: MMP12
5 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSFCAG00000000118
Gene Symbol: MMP13
5 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSFCAG00000006626
Gene Symbol: MMP14
5 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSFCAG00000005935
Gene Symbol: MMP2
5 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSFCAG00000015792
Gene Symbol: MMP3
5 Cross references
500 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSFCAG00000015787
Gene Symbol: MMP7
5 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSFCAG00000015790
Gene Symbol: MMP8
5 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSFCAG00000014014
Gene Symbol: MMP9
5 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSFCAG00000000053
Gene Symbol: MTOR
5 Cross references
224 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).